The next generation transcatheter pVAD
VenstraMedical is a medical device startup bringing an advanced percutaneous ventricular assist device (pVAD) capable of pumping 7 liter/min at 60mmHg of pressure in a collapsible, 9F delivery approach.
The problem
High mortality in cardiac patients experiencing:
Cardiogenic Shock:
• Cardiogenic shock typically occurs following a heart attack leading to a dangerously low cardiac output.
• Cardiogenic shock is the #1 cardio mortality risk in hospital.
Percutaneous Coronary Intervention (PCI):
• PCI is a procedure to implant a stent.
• For high risk patients, cardiac support devices are used to maintain blood flow during the procedure.
The solution
PVADs are becoming the standard of care
pVAD (percutaneous ventricular assist device):
A small blood pump placed at the catheter tip, implanted by a cardiologist into the patient’s heart to provide temporary cardiac support.
